Bliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on May 23, 2026.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma's board has noted a Share Purchase Agreement dated May 23, 2026, where Anupam Rasayan India Limited will acquire 43.30% stake (4.58 crore shares) from existing shareholders. The transaction is valued at ₹1,369.51 crore (₹299 per share). Promoter group members including Mr. Narsimha Shibroor Kamath (27.16%), Dr. Vibha Gagan Sharma (2.43%), and Ms. Shruti Vishal Rao (1.99%) are selling their holdings along with non-promoter shareholders. The deal will trigger an open offer for 26% of the company under SEBI Takeover Regulations. Post-transaction, Anupam Rasayan will become the new promoter and acquire control of the company.
This is a major change of control transaction that will likely result in the complete exit of existing promoters. The open offer requirement protects public shareholders. The stock may see significant price movement given the large deal size and change in promoter status.